The chaperonins are a subgroup of oligomeric molecular chaperones; the beststudied examples are chaperonin 60 (GroEL) and chaperonin 10 (GroES), both from the bacterium Escherichia coli. At the end of the 20th century, the paradigm of chaperonins as protein folders had emerged, but it is likely that during the 21st century these proteins will come to be viewed as intercellular signals. Indeed, it is possible that the chaperonins were among the first intercellular signalling proteins to evolve. During the past few years, it has emerged that chaperonin 10 and chaperonin 60 can be found on the surface of various prokaryotic and eukaryotic cells, and can even be released from cells. Secreted chaperonins can interact with a variety of cell types, including leukocytes, vascular endothelial cells and epithelial cells, and activate key cellular activities such as the synthesis of cytokines and adhesion proteins. Much has been made of the high degree of sequence conservation among the chaperonins, particularly in terms of the immunogenicity of these proteins. However, different chaperonin 60 proteins can bind to different cell-surface receptors, including the Toll-like receptors, suggesting that this family of proteins cannot be treated as one biological entity and that several subfamilies may exist. Chaperonins have been implicated in human diseases on the basis of their immunogenicity. The finding that chaperonins can also induce tissue pathology suggests that they may play roles in infections and in idiopathic diseases such as atherosclerosis and arthritis.
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The last decades of the 20th century saw the discovery of the heat-shock or cell-stress response (changes in the expression of certain proteins), and the elucidation of the function of the proteins that mediate this essential cellsurvival strategy. The stresses that can trigger this response vary widely, and include heat or cold, osmotic imbalance, toxins, heavy metals and pathophysiological signals such as cytokines and eicosanoids. The proteins that are synthesised in response to such environmental stresses have been variously called: heat-shock proteins (hsps), stress proteins or molecular chaperones. The term molecular chaperone, coined by Laskey and colleagues in 1978 (Ref. 1) , has been used in this review article. The cell-stress response is an evolutionarily ancient, ubiquitous and essential mechanism for cell survival. This fact is reflected in the conservation of the peptide sequences of the molecular chaperones throughout living organisms (Refs 2, 3). During the past 20 years, it has been established that, within the cytoplasm of the cell, the molecular chaperones interact with other proteins to fold, refold or maintain the folding of the interacting proteins (Ref. 4) . This mechanism protects cells from the damaging effects of environmental stresses, and the associated misfolding (denaturation) of intracellular proteins. Molecular chaperones are involved in many essential cellular functions, such as metabolism, growth, differentiation and programmed cell death, through protein assembly and transport. They also influence the activation of enzymes and receptors (Ref. 3) .
One of the first molecular chaperones to be identified was a 60-kDa protein, which has been given the generic term chaperonin 60 (cpn60; Ref. 5) . Fifteen different groups of proteins are now classified as molecular chaperones (Ref. 3 ; see Table 1 , for a description of the major families of chaperones). Many researchers worldwide are attempting to determine the mechanism of action of these various molecular chaperones, many of which exist as families of related proteins. This research effort is driven largely by the need to understand the roles that molecular chaperones play in normal cell functioning. However, increasing attention is being concentrated on the potential roles of these proteins in human diseases, including infection and idiopathic conditions such as arthritis and atherosclerosis. One subgroup of molecular chaperones, the chaperonins, has received the most attention (Ref. 6 ). The chaperonins consist of two protein Chaperonins are cell-signalling proteins: the unfolding biology of molecular chaperones 3 expert reviews in molecular medicine families, the chaperonin 60 family and the chaperonin 10 family. Because of the attention that the chaperonins have received, and the discovery that they have the additional property of acting as cell-to-cell signalling molecules, the chaperonins have formed the focus of this review.
The chaperonins: structure and function
The chaperonins are a well-characterised, sequence-related subgroup of molecular chaperones, which includes the GroE and TCP-1 (T-complex polypeptide 1) subclasses. The proteins of the GroE subclass, namely chaperonin 60 and chaperonin 10, have formed the subject of this review. To date, GroEL, the E. coli chaperonin 60 protein, is the most extensively studied molecular chaperone (Refs 7, 8, 9) . Together with GroES (the E. coli chaperonin 10 protein), GroEL is critical for the correct folding of many proteins in the cell, under both normal and stress conditions. The deletion of the 
The biology of chaperonins

Immunobiology of chaperonins
Chaperonins are potent immunogens (i.e. they induce a strong, specific immune response) in humans and rodents (see Table 2 ). This finding was established before the functions of the chaperonins were known (Refs 21, 22) , and has given rise to much immunological 'head scratching'. Infection is a stressful process, both for the pathogen and the host, and must, therefore, result in the increased production of molecular chaperones by both the pathogen and the host (Refs 23, 24). However, given the high degree of sequence similarity between bacterial and mammalian molecular chaperones, the immune reactivity to these bacterial proteins would be expected to be only minimal. The immune system is designed to ignore 'self', that is, host constituents; however, paradoxically, this is not the case with the chaperonins. It is still unclear why immunity to molecular chaperones is such a common and marked characteristic of infection (Refs 25, 26 later, mammalian chaperonin 10, which is also known as early pregnancy factor (EPF), is immunosuppressive during early pregnancy. Thus, molecular chaperones appear to suppress the immune system in some instances, probably by modulating T-cell function.
A very interesting (but highly controversial) hypothesis in this context is Matzinger's 'danger model', which attempts to explain immune responsiveness in terms of the recognition of host components that signal that the body is under attack. Molecular chaperones are one of the The literature abounds with controversy about the roles of molecular chaperones in immunity. This confusion might in part be due to the increasing evidence that molecular chaperones are not simply inert immunogens but can participate in lymphocyte activation. It has been suggested that molecular chaperones (particularly the chaperonins) should be classified as 'multiplex antigens' because of their ability to interact with, and activate, different cells. Many of these cells, including monocytes, dendritic cells and endothelial cells, can present antigens (Refs 26, 42). The ability of intact chaperonins and, as described later, chaperonin-derived peptides to activate antigen-presenting cells (APCs) may enhance antigen presentation, resulting in a greater lymphocyte response than would be induced by antigens that are inert and fail to activate the interacting leukocytes.
During the past 5 years, evidence has accumulated to support the hypothesis that molecular chaperones can activate a variety of cellular functions that might be important in tissue pathology, and that might also explain the immunoreactivity of these proteins. The chaperonins have received the most attention, and the literature on the biological activity of these proteins has been reviewed in the next section.
Chaperonins as intercellular signalling proteins
One should always expect the unexpected in life and this is particularly true in science. The 1990s were a period of enormous advancement in our understanding of the molecular, structural and cellular biology of the molecular chaperones. By the mid-1990s, understanding of the structure and function of the chaperonins was relatively clear. It was known that the two families of intracellular oligomeric proteins, whose synthesis could be dramatically increased under stressful conditions, could fold and refold other proteins intracellularly. However, while these studies of the structure-activity relationship of the protein- Chaperonin 60 proteins could be used in several different ways to treat bacterial infections. Bacterial isolates could be identified (or typed) by sequencing their chaperonin 60 proteins, and this might lead to better targeted treatments. Vaccines could potentially be made from bacterial chaperonin 60 proteins, and used to immunise the body against the pathogenic effects of the bacteria they are derived from. Alternatively, because chaperonin 60 proteins directly activate cells that lead to the inflammatory response, specific anti-chaperonin 60 antibodies could be used to block this response (fig002jrl). folding activity of the chaperonins were under way, other researchers were beginning to discover that the chaperonins had another, distinct set of functions. Perhaps the earliest indication that the chaperonins were likely to have actions other than protein folding was the report that chaperonin 60 could produce pores in membranes (Ref. 43 ).
Non-chaperone activities of chaperonin 60
The A very potent activity that has been ascribed to chaperonin 60 is bone resorption. Bone loss is a key factor in diseases such as Pott's disease (spinal tuberculosis) and periodontal disease, both of which are caused by bacterial infections, and also in osteoporosis. The chaperonin 60 protein from the bacterium Actinobacillus actinomycetemcomitans (which normally colonises the oral cavity) and that from E. coli (which normally colonises the gut) have been shown to be extremely active stimulators of the breakdown of murine calvarial bone in vitro (Ref. 50) . Surprisingly, the homologous chaperonin 60.2 (hsp65) proteins from M. tuberculosis and Mycobacterium leprae were very weak agonists of bone resorption in this model (Ref. 62). Thus, there are some differences in the biological action of these supposedly homologous proteins; these differences have been discussed in more detail in the next section. The analysis of the mechanism of action of GroEL on bone revealed that this protein acts as a growth factor for murine osteoclasts, which are the cells that break down the extracellular matrix of bone (Ref. 63 ). Other molecular chaperones (including hsp70 and hsp90) have also been found to stimulate bone resorption in in vitro models (Ref. 64) .
In addition to the actions of chaperonin 60 proteins on cytokine synthesis, several other activities have been ascribed to molecular chaperones that seem either to be independent of cytokine synthesis or to have an indirect effect on cytokine synthesis. Perhaps the most interesting report is that cultured human vascular endothelial cells respond to chaperonin 60 by upregulating the synthesis of the adhesion molecules that are involved in controlling leukocyte trafficking in inflammation. The chaperonin 60 proteins from M. tuberculosis (chaperonin 60.2) and E. coli induce the expression of intercellular adhesion molecule (ICAM), vascular cell adhesion molecule (VCAM) and E-selectin by human vascular endothelial cells (Refs 65, 66). The induction of the transcription of the genes encoding these three adhesion proteins is controlled by pro-inflammatory cytokines including interleukin 1 (IL-1) and tumour necrosis factor alpha (TNF-α), and therefore the actions of chaperonin 60 proteins on these three proteins would be expected to involve the synthesis of these two cytokines. However, the M. tuberculosis and E. coli chaperonin 60 proteins induce human vascular endothelial cells to transcribe the genes for these adhesion proteins independently of the induction of the synthesis of either IL-1 or TNF-α, via another signalling pathway. As already mentioned, there is a great deal of interest in the role of chaperonin 60 in the pathology of atherosclerosis; therefore, the finding that chaperonin 60 can directly activate endothelial cells, which are central to the pathogenesis of this disease, is important, and of therapeutic and/or prophylactic interest.
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Biological activities of chaperonin 10
The biology of chaperonin 10, a small heptameric protein, has received less attention than that of chaperonin 60. However, the role of human chaperonin 10 in the biology of EPF is still being actively debated. EPF is a secreted protein that has growth regulatory and immunomodulatory actions, both of which are required for the successful establishment of pregnancy, at least in a rodent model (Refs 74, 75) . The purification and sequencing of EPF from rats have led to its identification as mammalian chaperonin 10 (Ref. In addition to stimulating the breakdown of bone in in vitro assays and cell cultures, M. tuberculosis chaperonin 10 can also induce human monocytes in vitro to synthesise and secrete pro-inflammatory cytokines. Structureactivity studies, using synthetic peptides, have revealed that the active site of M. tuberculosis chaperonin 10 is in the C-terminal helical domain. This domain is distinct from those that induce bone resorption by osteoclasts, suggesting that this small protein has at least two distinct sites for the activation of myeloid cells (P. Tabona and colleagues, Eastman Dental Institute, London, UK, unpublished).
Chaperonins: the unanswered questions
Release of chaperonins from cells
Only 7 years have passed since it was first reported that chaperonins might stimulate cells. There is now substantial supportive evidence Chaperonins are cell-signalling proteins: the unfolding biology of molecular chaperones 10 expert reviews in molecular medicine for the hypothesis that chaperonins, when added to the external environment of cells in vitro, can act as intercellular signals. However, the key question 'Do chaperonins act as intercellular signals in vivo?' still needs to be answered. Many researchers studying molecular chaperones have the fixed idea that these proteins are intracellular, and therefore that any extracellular effects that are reported are artefactual. The reason for this is that, at present, there is no known mechanism to explain how cells can secrete molecular chaperones. At first sight, this knowledge gap seems to represent a significant problem for those studying the cell-to-cell signalling properties of molecular chaperones. However, to date, there is no known mechanism to explain the secretion of the potent proinflammatory cytokine IL-1 or the well-known redox chaperone protein thioredoxin (Ref. 82 ). Yet no one would discount the evidence that both of these proteins are potent and important secreted cell-to-cell signalling molecules. Fortunately, evidence has begun to accumulate in recent years to support the hypothesis that host-derived molecular chaperones can be released from cells as part of normal homeostatic control. Indeed, certain bacteria release large amounts of these proteins. For example, an early publication reported that chaperonin 10 made up 20% of the total protein content of culture filtrates of logarithmically growing M. tuberculosis (Ref. 83 ). An increasing number of studies have reported that chaperonin 60 is either found on the surface of bacteria or actively secreted by them. For example, at least some of the chaperonin 60 protein in A. actinomycetemcomitans is associated with its cell surface (Ref. . In this species of bacterium, the surface-expressed chaperonin 60 is believed to act as an adhesin (a protein that is responsible for the adhesion of the bacterium to host tissues). Initially, controversy existed as to whether the surface expression of this chaperonin was due to it being either actively secreted by the bacteria or simply the result of bacterial lysis. However, it has recently been conclusively demonstrated that the expression of chaperonin 60 on the Fig. 4 ).
Chaperonin biology: structure-activity relationships and receptors
The chaperonin 60 family of proteins is highly conserved, even between such unrelated species as bacteria and humans. The degree of sequence conservation between individual bacterial species is in the order of 50-60%. Thus, it has been thought convenient to regard these 60-kDa chaperonin proteins as identical biological molecules. This is certainly the working hypothesis of those who are interested in the folding properties of chaperonin 60 proteins. This was also our viewpoint until our group discovered (Ref. An obvious question that has to be addressed is 'How do molecular chaperones activate cells?' The simplest hypothesis is that they bind to a cell-surface receptor, and activate cells via one or more intracellular signalling pathways. In a recent report, Kol and colleagues (Ref. 58) presented evidence that murine monocytes respond to both human and chlamydial chaperonin 60 proteins via the LPS CD14 receptor. CD14 is a glycosylphosphatidyl-inositol-anchored nonsignalling receptor, which interacts with a second class of receptor, known as Toll-like receptors (TLRs), to induce cell activation (Ref. 106 ). The TLR that recognises LPS is now known to be TLR4. This work relied, in part, on the finding that anti-CD14 monoclonal antibodies blocked the activity of the chaperonin 60 proteins used in these studies. However, our group reported previously that anti-CD14 monoclonal antibodies did not block the activation of human monocytes by GroEL (Ref. 52); we have also shown that the activity of the M. tuberculosis chaperonin 60.1 and chaperonin 60.2 proteins is unaffected by anti-CD14 monoclonals (J. Lewthwaite and colleagues, Eastman Dental Institute, London, UK, unpublished). Further evidence that GroEL does not function via the complex formed between the CD14 receptor and the TLR comes from earlier published work, in which we used the C3H/HeJ LPS-unresponsive mouse strain. Bone derived from these mice was, as expected, unresponsive to LPS but underwent osteolysis in the presence of GroEL. Because the basic defect in these mice resides in the TLR4, which is nonfunctional owing to the mutation of a single base in its DNA, the CD14-TLR4 complex is ruled out as the receptor for either GroEL or the M. tuberculosis and M. leprae chaperonin 60 proteins. Further evidence to support this hypothesis comes from the use of signal-transduction inhibitors. Our group has shown that inhibitors of p38 mitogenactivated protein kinase block both LPS-and GroEL-activated human monocytes, but that only GroEL-activated monocytes are blocked by inhibitors of the src family of kinases (P. Tabona and colleagues, unpublished).
The preliminary conclusion that can be reached from all these studies is that human cells have more than one receptor for chaperonin 60 proteins. Thus, different chaperonin 60 proteins may be able to bind to different receptors on human cells and produce different patterns of cell activation.
Chaperonin biology: the future
Chaperonins are released from cells and/or are expressed on external cell membranes (of both eukaryotic and prokaryotic cells), and thereby become part of the population of proteins that act as cell-to-cell signals. Is signalling one of the evolved properties of chaperonins, or is it simply an artefact of the inappropriate release of these proteins? We believe the ability to signal to cells and activate them is a key attribute of a stress protein. Studies of molecular chaperones and their induction in response to stress have largely been performed in in vitro culture systems; in such systems, all cells are exposed to the same stress signals and do not, therefore, need to signal to other cells. But what happens in vivo? If cells in one part of a tissue (or in one tissue) are exposed to stress, it would be sensible to broadcast this 'news' to the rest of the tissue or organism. The simplest method of doing this would be to use the molecular chaperones, whose synthesis has been increased by the organism, to act as the messengers to signal to other cells that stressful events are occurring within their immediate environment. Indeed, the finding that human ADNF, a neuronal stress protein, can upregulate the expression of human chaperonin 60 in neuronal cells is the first example of molecular chaperones upregulating the synthesis of additional molecular chaperones. We would predict that this is likely to be a common mechanism by which molecular chaperones act to spread the 'bad news' about stress, so that the body can react appropriately to minimise its effects.
If the hypothesis that molecular chaperones are cell-to-cell signalling proteins is correct, then these proteins could play pathological roles in human diseases, and therefore be targets for therapeutic intervention. It is likely that the direct roles of molecular chaperones in human diseases will be defined in the near future. Tables   Table 1. Diversity of the major molecular chaperone families (tab001jrl). Table 2 . Evidence for the involvement of chaperonins in disease (tab002jrl). 
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